Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Individualised treatment plans for the treatment and management of genetic complications of the disease, usually including drug therapy, rehabilitation interventions, regular follow-up, etc.
, are needed. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neurological diseases that have previously been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the genetics of Chia disease. The platform serves a team of experts at home and abroad in the field of neural systems linked to the China International Medical Service System, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.